These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3805250)

  • 1. Neuropsychology of multiple sclerosis: a critical review.
    Rao SM
    J Clin Exp Neuropsychol; 1986 Oct; 8(5):503-42. PubMed ID: 3805250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychological and neuropsychological problems in multiple sclerosis].
    Béquet D; Taillia H; Clervoy P; Renard JL; Flocard F
    Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological aspects of childhood multiple sclerosis: an overview.
    Blaschek A; Storm van's Gravesande K; Heinen F; Pritsch M; Mall V; Calabrese P
    Neuropediatrics; 2012 Aug; 43(4):176-83. PubMed ID: 22605613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH; Carone DA; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients?
    Patti F; Di Stefano M; De Pascalis D; Ciancio MR; De Bernardis E; Nicoletti F; Reggio A
    Funct Neurol; 1995; 10(2):83-90. PubMed ID: 7557556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
    Rosti-Otajärvi E; Hämäläinen P
    Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
    Wegener S; Marx I; Zettl UK
    Fortschr Neurol Psychiatr; 2013 Nov; 81(11):639-47. PubMed ID: 24194057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and emotional disturbances in multiple sclerosis.
    Beatty WW
    Neurol Clin; 1993 Feb; 11(1):189-204. PubMed ID: 8441370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter disease and dementia.
    Rao SM
    Brain Cogn; 1996 Jul; 31(2):250-68. PubMed ID: 8812003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological investigations of multiple sclerosis: a clinical perspective.
    O'Connor MG
    Clin Neurosci; 1994; 2(3-4):225-8. PubMed ID: 7749892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.
    Tekok-Kilic A; Benedict RH; Zivadinov R
    Expert Rev Neurother; 2006 Mar; 6(3):323-31. PubMed ID: 16533137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological evaluation and treatment of multiple sclerosis: the importance of a neuro-rehabilitation focus.
    Pepping M; Ehde DM
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):411-36, viii. PubMed ID: 15893679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.